Assessment of clinical and economic impact of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States

Shah, Anshul ; Dabbous, Firas ; Shah, Surbhi ; Ashton, Veronica ; Kharat, Akshay

Journal of medical economics, 2024-12, Vol.27 (1), p.10-15 [Periódico revisado por pares]

England

Texto completo disponível